Patent · US Expired

2[3-(4-Chlorophenyl)-1,2-dimethyl-1H-indol-5-yloxy]-2-methyl propanoic acid and hyperlipidemic or atheosclerotic use thereof

US4343811A · kind A · utility

10Cited by

1References

5Claims

0Family size

Assignee

Boehringer Ingelheim GmbH · DE

Inventors

Rudolf Hurnaus · Großenhain, DE
Gerhart Griss · Zell am Harmersbach, DE
Wolfgang Grell · Biberach, DE
Robert Sauter · Biberach, DE
Bernhard Eisele · Biberach, DE
Nikolaus Kaubisch · Biberach, DE
Eckhard Rupprecht · Dinkelsbühl, DE
Joachim Kahling · Biberach, DE

Key dates

Filing date	Feb 29, 1980
Grant date	Aug 10, 1982
Priority date	—
Expiry date	Feb 29, 2000

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention relates to novel indole derivatives of formula ##STR1## and the non-toxic, pharmacologically acceptable salts thereof. These compounds exhibit desirable pharmacological properties, especially lipid-level lowering and anti-atherosclerotic activity. The compounds of the invention may be prepared by, for example, alkylation of a corresponding hydroxy indole.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.